FDA-Registered At-Home Vision Testing Company With 29 Patents and Nationwide Telehealth Reach

This San Jose-based diagnostics company holds the only fully commercialized, clinically validated, FDA-registered platform for at-home vision testing, built around a 29-patent portfolio and optical technology licensed exclusively from MIT. Its HIPAA-compliant telehealth network issues prescriptions in 40 U.S. states, and the company has shipped more than 50,000 devices to over 150 countries across eight years of operation without a single product defect, medical device report, or litigation claim. The portfolio includes seven FDA-registered devices and apps, certifications spanning ISO 13485, ISO 9001, and HIPAA, and four active clinical trials registered on ClinicalTrials.gov. Established in 2015 and employing seven people, the business has attracted roughly $31 million in development investment and built blue-chip partnerships with national pharmacy chains and major health systems, alongside a proprietary vision dataset suited for AI applications. Reported revenue stands at $359,491 with cash flow of $28,490, and furniture, fixtures, and equipment are valued at $100,000. The current ownership is selling to position the company for its next stage of growth and continued global commercialization.